Based on the Minerva Surgical Inc stock forecast from 0 analysts, the average analyst target price for Minerva Surgical Inc is not available over the next 12 months. Minerva Surgical Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Minerva Surgical Inc is Very Bearish, which is based on 0 positive signals and 7 negative signals. At the last closing, Minerva Surgical Inc’s stock price was USD 0.00. Minerva Surgical Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -90.00% over the last year.
No recent analyst target price found for Minerva Surgical Inc
No recent average analyst rating found for Minerva Surgical Inc
Company Overview Minerva Surgical Inc
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California. Read Less
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genes...Read More
Frequently Asked Questions About Minerva Surgical Inc (UTRS) Stock
Stock Target Advisor's fundamental analysis for Minerva Surgical Inc's stock is Very Bearish.
Unfortunately we do not have enough data on UTRS's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on UTRS's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on UTRS's stock to indicate if its overvalued.
The last closing price of UTRS's stock was USD 0.00.
The most recent market capitalization for UTRS is USD 888.00.
Unfortunately we do not have enough analyst data on UTRS's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Minerva Surgical Inc's stock.
As per our most recent records Minerva Surgical Inc has 174 Employees.
Minerva Surgical Inc's registered address is 4255 Burton Drive, Santa Clara, CA, United States, 95054.
You can get more information about it from Minerva Surgical Inc's website at https://minervasurgical.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Minerva Surgical Inc (UTRS) Stock
Stock Target Advisor's fundamental analysis for Minerva Surgical Inc's stock is Very Bearish.
Unfortunately we do not have enough data on UTRS's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on UTRS's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on UTRS's stock to indicate if its overvalued.
The last closing price of UTRS's stock was USD 0.00.
The most recent market capitalization for UTRS is USD 888.00.
Unfortunately we do not have enough analyst data on UTRS's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Minerva Surgical Inc's stock.
As per our most recent records Minerva Surgical Inc has 174 Employees.
Minerva Surgical Inc's registered address is 4255 Burton Drive, Santa Clara, CA, United States, 95054.
You can get more information about it from Minerva Surgical Inc's website at https://minervasurgical.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for UTRS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
